1 Study Coverage
1.1 Anca Vasculitis Drug Product Introduction
1.2 Market Segments
1.3 Key Anca Vasculitis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anca Vasculitis Drug Market Size Growth Rate by Type
1.4.2 Belimumab
1.4.3 CCX-1378
1.4.4 CCX-168
1.4.5 Dalazatide
1.4.6 Others
1.5 Market by Application
1.5.1 Global Anca Vasculitis Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anca Vasculitis Drug Market Size, Estimates and Forecasts
2.1.1 Global Anca Vasculitis Drug Revenue 2015-2026
2.1.2 Global Anca Vasculitis Drug Sales 2015-2026
2.2 Global Anca Vasculitis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anca Vasculitis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anca Vasculitis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anca Vasculitis Drug Competitor Landscape by Players
3.1 Anca Vasculitis Drug Sales by Manufacturers
3.1.1 Anca Vasculitis Drug Sales by Manufacturers (2015-2020)
3.1.2 Anca Vasculitis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Anca Vasculitis Drug Revenue by Manufacturers
3.2.1 Anca Vasculitis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Anca Vasculitis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anca Vasculitis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anca Vasculitis Drug Revenue in 2019
3.2.5 Global Anca Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anca Vasculitis Drug Price by Manufacturers
3.4 Anca Vasculitis Drug Manufacturing Base Distribution, Product Types
3.4.1 Anca Vasculitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anca Vasculitis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Anca Vasculitis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anca Vasculitis Drug Market Size by Type (2015-2020)
4.1.1 Global Anca Vasculitis Drug Sales by Type (2015-2020)
4.1.2 Global Anca Vasculitis Drug Revenue by Type (2015-2020)
4.1.3 Anca Vasculitis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anca Vasculitis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Anca Vasculitis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Anca Vasculitis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Anca Vasculitis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anca Vasculitis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anca Vasculitis Drug Market Size by Application (2015-2020)
5.1.1 Global Anca Vasculitis Drug Sales by Application (2015-2020)
5.1.2 Global Anca Vasculitis Drug Revenue by Application (2015-2020)
5.1.3 Anca Vasculitis Drug Price by Application (2015-2020)
5.2 Anca Vasculitis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Anca Vasculitis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Anca Vasculitis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Anca Vasculitis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anca Vasculitis Drug by Country
6.1.1 North America Anca Vasculitis Drug Sales by Country
6.1.2 North America Anca Vasculitis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anca Vasculitis Drug Market Facts & Figures by Type
6.3 North America Anca Vasculitis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Anca Vasculitis Drug by Country
7.1.1 Europe Anca Vasculitis Drug Sales by Country
7.1.2 Europe Anca Vasculitis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anca Vasculitis Drug Market Facts & Figures by Type
7.3 Europe Anca Vasculitis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anca Vasculitis Drug by Region
8.1.1 Asia Pacific Anca Vasculitis Drug Sales by Region
8.1.2 Asia Pacific Anca Vasculitis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anca Vasculitis Drug Market Facts & Figures by Type
8.3 Asia Pacific Anca Vasculitis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anca Vasculitis Drug by Country
9.1.1 Latin America Anca Vasculitis Drug Sales by Country
9.1.2 Latin America Anca Vasculitis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anca Vasculitis Drug Market Facts & Figures by Type
9.3 Central & South America Anca Vasculitis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anca Vasculitis Drug by Country
10.1.1 Middle East and Africa Anca Vasculitis Drug Sales by Country
10.1.2 Middle East and Africa Anca Vasculitis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anca Vasculitis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Anca Vasculitis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 ChemoCentryx, Inc.
11.1.1 ChemoCentryx, Inc. Corporation Information
11.1.2 ChemoCentryx, Inc. Description and Business Overview
11.1.3 ChemoCentryx, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Products Offered
11.1.5 ChemoCentryx, Inc. Related Developments
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Corporation Information
11.2.2 GlaxoSmithKline plc Description and Business Overview
11.2.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline plc Anca Vasculitis Drug Products Offered
11.2.5 GlaxoSmithKline plc Related Developments
11.3 Kineta, Inc.
11.3.1 Kineta, Inc. Corporation Information
11.3.2 Kineta, Inc. Description and Business Overview
11.3.3 Kineta, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Kineta, Inc. Anca Vasculitis Drug Products Offered
11.3.5 Kineta, Inc. Related Developments
11.1 ChemoCentryx, Inc.
11.1.1 ChemoCentryx, Inc. Corporation Information
11.1.2 ChemoCentryx, Inc. Description and Business Overview
11.1.3 ChemoCentryx, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Products Offered
11.1.5 ChemoCentryx, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anca Vasculitis Drug Market Estimates and Projections by Region
12.1.1 Global Anca Vasculitis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Anca Vasculitis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.2.2 North America: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anca Vasculitis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anca Vasculitis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anca Vasculitis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
ChemoCentryx, Inc.、GlaxoSmithKline plc、Kineta, Inc.
【免責事項】
https://www.globalresearch.jp/disclaimer